Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Disease Progression and CD38[original query] |
|---|
| The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers, in vitro sensitivity to fludarabine, Bcl-2 family protein expression or survival in B-cell chronic lymphocytic leukaemia. British journal of haematology 2003 Oct 123 (1): 66-71. Starczynski Jane, Pepper Chris, Pratt Guy, Hooper Laura, Thomas Alun, Hoy Terry, Milligan Donald, Bentley Paul, Fegan Christoph |
| 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome. European journal of haematology 2004 Apr 72 (4): 259-63. Nückel H, Frey UH, Dürig J, Dührsen U, Siffert W |
| Human leukocyte antigen class II allele association to disease progression in Iranian patients with chronic lymphocytic leukemia. Human immunology 2008 Oct 69 (10): 666-74. Hojjat-Farsangi Mohammad, Jeddi-Tehrani Mahmood, Amirzargar Ali Akbar, Razavi Seyed Mohsen, Sharifian Ramazan Ali, Rabbani Hodjatallah, Shokri Faz |
| The role of G protein gene GNB3 C825T polymorphism in HIV-1 acquisition, progression and immune activation. Retrovirology 2012 9 (1): 1. Juno Jennifer, Tuff Jeffrey, Choi Robert, Card Catherine, Kimani Joshua, Wachihi Charles, Koesters-Kiazyk Sandra, Ball T Blake, Farquhar Carey, Plummer Francis A, John-Stewart Grace, Luo Ma, Fowke Keith |
| Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia. HLA 2016 May . Butrym A, Gebura K, Iwaszko M, Kuliczkowski K, Bogunia-Kubik K, Mazur |
| Leukemia-cell proliferation and disease progression in patients with early stage chronic lymphocytic leukemia. Leukemia 2017 1 31 (6): 1348-1354. Murphy E J, Neuberg D S, Rassenti L Z, Hayes G, Redd R, Emson C, Li K, Brown J R, Wierda W G, Turner S, Greaves A W, Zent C S, Byrd J C, McConnel C, Barrientos J, Kay N, Hellerstein M K, Chiorazzi N, Kipps T J, Rai K |
| Examination of clonal evolution in chronic lymphocytic leukemia. Medical oncology (Northwood, London, England) 2019 Aug 36 (9): 79. Koczkodaj Dorota, Popek-Marciniec Sylwia, Zmorzy?ski Szymon, W?sik-Szczepanek Ewa, Filip Agata |
| TLR9 polymorphism correlates with immune activation, CD4 decline and plasma IP10 levels in HIV patients. BMC infectious diseases 2019 Jan 19 (1): 56. Joshi Anjali, Punke Erin B, Mehmetoglu-Gurbuz Tugba, Peralta Diego P, Garg Himans |
| Time to first treatment and P53 dysfunction in chronic lymphocytic leukaemia: results of the O-CLL1 study in early stage patients. Scientific reports 2020 10 10 (1): 18427. Monti Paola, Lionetti Marta, De Luca Giuseppa, Menichini Paola, Recchia Anna Grazia, Matis Serena, Colombo Monica, Fabris Sonia, Speciale Andrea, Barbieri Marzia, Gentile Massimo, Zupo Simonetta, Dono Mariella, Ibatici Adalberto, Neri Antonino, Ferrarini Manlio, Fais Franco, Fronza Gilberto, Cutrona Giovanna, Morabito Fortuna |
| Revisiting Autoimmunity in Chronic Lymphocytic Leukemia: Prognostic Value of Positive Direct Antiglobulin Test in a Retrospective Study and Literature Review. Journal of blood medicine 2021 4 12 225-234. Ahmed Shimaa A, Abdallah Ghada E M, Aly Mai M, Abdelsalam Eman M Nagiub, Mohammed Saleh Mostafa |
- Page last reviewed:Feb 1, 2024
- Content source: